Results 271 to 280 of about 50,964 (281)

Castration-resistant Prostate Cancer

2016
Vikash Kumar, Tejinder Kataria, Sandeep Batra   +2 more
openaire   +1 more source

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

New England Journal of Medicine, 2010
Philip W Kantoff, Eric J Small, Charles H Redfern   +2 more
exaly  

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

New England Journal of Medicine, 2018
Maha Hussain, Karim Fizazi, Fred Saad
exaly  

Castration-Resistant Prostate Cancer

2015
openaire   +2 more sources

The changing therapeutic landscape of castration-resistant prostate cancer

Nature Reviews Clinical Oncology, 2011
Timothy A Yap, Andrea Zivi, Johann S de Bono   +2 more
exaly  

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Lancet, The, 2011
Michael Carducci, Ronaldo Damiao, Janet E Brown   +2 more
exaly  

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Annals of Oncology, 2010
G Sonpavde, D Weckstein, M D Galsky
exaly  

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Lancet, The, 2010
Johann S de Bono, Stéphane Oudard, Mustafa Ozguroglu   +2 more
exaly  

Castrate-Resistant Prostate Cancer

2014
openaire   +1 more source

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial

Annals of Oncology, 2015
David Cella, J Spalding
exaly